It remains to be seen how much
the issue of embryonic stem cell research will play in one of the nation's most closely watched and hard - fought Senate elections.
Take
the issue of embryonic stem cells.
Not exact matches
In addition, scientific journals continue to push the
issue of embryonic stem -
cell research in their editorial and commentary sections, using it as a prime criterion to grade political candidates.
(i) a woman's right to an abortion; (iii) medical immunization
of teen girls (and boys) against HPV; (iv) assisted suicide; (vi) gay marriage; (vii) my right to view art and theatre deemed «offensive,» «blasphemous» or «obscene» Catholics; (viii) basic $ ex education for older school children; (ix) treating drug abuse as principally a medical
issue; (x) population control; (xi) buying alcohol on a Sunday in many places; (xii) use
of condoms and other contraceptives; (xiii)
embryonic stem cell research; (xiv) little 10 year - old boys joining organizations such as the Boy Scouts
of America, regardless
of the religious views
of their parents; and (xv) gays being allowed to serve openly in the military.
The isolation
of embryonic stem cells by Dr. James Thomson in 1998 put the
issue of stem cell research on the map.
The year's most prominent science
issue, federal support
of embryonic stem cell research, is so controversial that the sons
of Ronald Reagan gave dueling speeches at the opposing party conventions; Michael Reagan backs President George W. Bush's policies, including the ban on funding for research on new
stem cell lines, while Ron supports Senator John Kerry's promise to lift restrictions.
In March, advocate general Yves Bot
issued a preliminary judgment limiting patents involving
embryonic stem cells, on the basis that they «would be contrary to ethics and public policy» (see «European Court
of Justice rejects
stem -
cell patents»).
Existing European patents involving
embryonic stem cells — most
of which were
issued in the United Kingdom — will not be invalidated immediately, but lawsuits challenging individual patents will use the ruling as guidance.
Now, many research advocates are wondering how Price's mix
of views might play out in the new administration's approach to a wide range
of issues, including funding, research involving human
embryonic stem cells and fetal tissue, and the appointment
of a new NIH director.
The final guidelines on research with human
embryonic stem cells issued on Monday by the National Institutes
of Health set out criteria for determining which ES
cell lines can be used in federally funded experiments and give NIH discretion to approve old lines that don't meet stringent modern ethical requirements.
In the past few weeks, the debate about genetic research in Germany has focused on the
issue of the use
of embryonic stem cells for research.
The Bundestag faces a heated debate on 30 January, when the
issue of whether to allow the import
of human
embryonic stem cells for research purposes is on the agenda.
The ethics council finally
issued its 20 - page report just before Christmas, voting in favor
of allowing the import
of human
embryonic stem cells, under certain conditions, by a small majority
of 15 to 9, paving the way for next week's final showdown.
«We are in an era where the primary
issues are not federal funding for human
embryonic stem cell research,» wrote CAMR President Amy Comstock Rick, who is also CEO
of the Parkinson's Action Network, in an e-mail to the more than 100 patient advocacy, scientific, and other groups that belong to CAMR.
«We studied how the Sox2 gene is turned on in mice, and found the region
of the genome that is needed to turn the gene on in
embryonic stem cells,» said Professor Jennifer Mitchell
of U
of T's Department
of Cell and Systems Biology, lead invesigator
of a study published in the December 15
issue of Genes & Development.
He has guided us through such
issues as the organ donor market (he opposed the sale
of kidneys to the highest bidder), the Terri Schiavo case (he opposed government intervention to keep her alive), and the
stem cell wars (he supports
embryonic stem cell research).
Thirteen European
stem cell scientists have
issued a public appeal to the European Court
of Justice (ECJ) not to prohibit patents on discoveries made with human
embryonic stem (hES)
cells.
They don't require the use
of embryos, so they avoid some
of the ethical and legal
issues that have complicated research with
embryonic stem cells.
He's engaging in classic hype that the religious right uses whenever this
issue comes up — claiming that we don't really need
embryonic stem cells because adult
stem cells are so wonderful that they can take care
of everything.
Critical
issues include: (i) heterogeneity in
stem cell populations (ii) regulation of cell fate choices; (iii) declining tissue performance with age and exposure to environmental injuries; (iv) the use of iPS and Embryonic Stem (ES) cells, and reprogramming methods for phenotyping disease states and potential use of these stem cells in the cli
stem cell populations (ii) regulation
of cell fate choices; (iii) declining tissue performance with age and exposure to environmental injuries; (iv) the use
of iPS and
Embryonic Stem (ES) cells, and reprogramming methods for phenotyping disease states and potential use of these stem cells in the cli
Stem (ES)
cells, and reprogramming methods for phenotyping disease states and potential use
of these
stem cells in the cli
stem cells in the clinic.
The National Research Council and Institute
of Medicine released amended guidelines for research involving human
embryonic stem cells, revising those that were
issued in 2005 and updated in 2007.
This work is highly relevant to the
issues of human reproductive cloning and research on human
embryonic stem cells.
Reference: September 13, 2007
issue of Cell Stem Cell under the title «Whole - Genome Mapping
of Histone H3Lys4 and 27 Trimethylations Reveals Distinct Genomic Compartments in Human
Embryonic Stem Cells».
Topics covered include
embryonic stem cells, pluripotency, germline
stem cells, tissue - specific
stem cells,
stem cell differentiation, epigenetics,
stem cell genomics and systems biology, genome reprogramming, cancer
stem cells,
stem cell niches,
stem -
cell - based disease models, nuclear transfer technology, bioengineering, drug discovery, in vivo imaging
of stem cells, therapeutic applications, regenerative medicine, clinical and translational insights,
stem cell research policies, ethical
issues, and technical or resource - based innovations.
Washington, DC (LifeNews.com)-- As the Senate prepares to tackle the thorny
issue of forcing taxpayers to fund
embryonic stem cell research in the coming weeks, two senators are reintroducing a bill that would institute a national ban on all forms
of human cloning.
Dr Harris normally took a libertarian stand on bioethical
issues and was a forceful and reliable supporter
of human
embryonic stem cell research, abortion, euthanasia, anonymous sperm donation, IVF for lesbians and single parents and so on.